- Home
- MUFG vs BSX Comparison
MUFG vs BSX Comparison
Compare MUFG & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MUFG | BSX |
|---|---|---|
| Founded | 1880 | 1979 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 179.9B | 149.7B |
| IPO Year | 2001 | 1992 |
Fundamental Metrics
Financial Performance| Metric | MUFG | BSX |
|---|---|---|
| Price | $16.25 | $97.32 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 19 |
| Target Price | N/A | ★ $124.53 |
| AVG Volume (30 Days) | 4.3M | ★ 8.9M |
| Earning Date | 11-14-2025 | 10-22-2025 |
| Dividend Yield | ★ 1.33% | N/A |
| EPS Growth | N/A | ★ 54.68 |
| EPS | 0.76 | ★ 1.87 |
| Revenue | ★ $38,565,096,137.00 | $19,349,000,000.00 |
| Revenue This Year | $2.23 | $21.05 |
| Revenue Next Year | $7.31 | $11.43 |
| P/E Ratio | ★ $21.03 | $52.15 |
| Revenue Growth | N/A | ★ 21.61 |
| 52 Week Low | $10.46 | $85.98 |
| 52 Week High | $16.39 | $109.50 |
Technical Indicators
Market Signals| Indicator | MUFG | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 64.94 | 41.77 |
| Support Level | $15.63 | $100.50 |
| Resistance Level | $16.39 | $101.91 |
| Average True Range (ATR) | 0.25 | 2.03 |
| MACD | 0.08 | -0.30 |
| Stochastic Oscillator | 90.43 | 19.87 |
Price Performance
Historical ComparisonAbout MUFG Mitsubishi UFJ Financial Group Inc.
Mitsubishi UFJ Financial Group is the largest bank in Japan in terms of market capitalization and assets, with an 8.4% share of all domestic loans as of March 2025. It is the largest non-Chinese bank group globally and has a balance sheet slightly larger than those of JPMorgan Chase and HSBC Holdings. MUFG's operations in Japan account for around half of profit, banking in Thailand and Indonesia for around 15%, and equity-method earnings from Morgan Stanley most of the rest.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.